(Q38096870)

28 August 2017

title

Application of aptamers for targeted therapeutics (English)

1 reference

28 August 2017

Partha Ray

1

1 reference

28 August 2017

Kristi D Viles

series ordinal

2

1 reference

28 August 2017

Erin E Soule

series ordinal

3

1 reference

28 August 2017

Rebecca Smock Woodruff

series ordinal

4

1 reference

28 August 2017

publication date

7 April 2013

1 reference

Archivum Immunologiae et Therapiae Experimentalis

28 August 2017

published in

1 reference

28 August 2017

volume

61

1 reference

28 August 2017

issue

4

1 reference

28 August 2017

page(s)

255-271

1 reference

Post-SELEX chemical optimization of a trypanosome-specific RNA aptamer

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Factors affecting the clearance and biodistribution of polymeric nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

AS1411 aptamer tagged PLGA-lecithin-PEG nanoparticles for tumor cell targeting and drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Quantum dot-aptamer conjugates for synchronous cancer imaging, therapy, and sensing of drug delivery based on bi-fluorescence resonance energy transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Locked nucleic acid aptamers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Antiproliferative activity of G-rich oligonucleotides correlates with protein binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

In vitro Selection of DNA Aptamers to Glioblastoma Multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

A new classification for HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Immunoglobulin-like cell adhesion molecules: novel signaling players in epithelial ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Development of aptamer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Targeting Axl with an high-affinity inhibitory aptamer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Evolution of a T7 RNA polymerase variant that transcribes 2'-O-methyl RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Aptamer-based endocytosis of a lysosomal enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Fluorescent, superparamagnetic nanospheres for drug storage, targeting, and imaging: a multifunctional nanocarrier system for cancer diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Aptamer:toxin conjugates that specifically target prostate tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Aptamer mediated siRNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

An aptamer that neutralizes R5 strains of HIV-1 binds to core residues of gp120 in the CCR5 binding site

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

A tenascin-C aptamer identified by tumor cell SELEX: systematic evolution of ligands by exponential enrichment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Structural characterization of an anti-gp120 RNA aptamer that neutralizes R5 strains of HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

An aptamer that neutralizes R5 strains of human immunodeficiency virus type 1 blocks gp120-CCR5 interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Broad-spectrum aptamer inhibitors of HIV reverse transcriptase closely mimic natural substrates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Selection of an RNA molecule that mimics a major autoantigenic epitope of human insulin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Translocations involving anaplastic lymphoma kinase (ALK).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Let's get specific: the relationship between specificity and affinity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

In vitro selection of RNA molecules that bind specific ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

A neutralizing RNA aptamer against EGFR causes selective apoptotic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Delivery of chlorambucil using an acoustically-triggered perfluoropentane emulsion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Nanoparticle-aptamer bioconjugates for cancer targeting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

DNA aptamers that bind to MUC1 tumour marker: design and characterization of MUC1-binding single-stranded DNA aptamers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Phototoxic aptamers selectively enter and kill epithelial cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Multifunctional magnetic nanoparticles: design, synthesis, and biomedical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Precise glioma targeting of and penetration by aptamer and peptide dual-functioned nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Whole-cell SELEX aptamer-functionalised poly(ethyleneglycol)-poly(ε-caprolactone) nanoparticles for enhanced targeted glioblastoma therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

MUC1, the renaissance molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Nucleolin functions in the first step of ribosomal RNA processing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Diversity of oligonucleotide functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Biodegradable long-circulating polymeric nanospheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Tenascin-C aptamers are generated using tumor cells and purified protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Surface expressed nucleolin is constantly induced in tumor cells to mediate calcium-dependent ligand internalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Novel MUC1 aptamer selectively delivers cytotoxic agent to cancer cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

The angiogenic function of nucleolin is mediated by vascular endothelial growth factor and nonmuscle myosin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Molecular assembly of an aptamer-drug conjugate for targeted drug delivery to tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Heat-sensitive microbubbles for intraoperative assessment of cancer ablation margins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

ERBB receptors and cancer: the complexity of targeted inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Discovery and development of anticancer aptamers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Ion selective folding of loop domains in a potent anti-HIV oligonucleotide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

A liposome-based nanostructure for aptamer directed delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Photoresponsive DNA-cross-linked hydrogels for controllable release and cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Near-infrared light-responsive core-shell nanogels for targeted drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

SELEX with modified nucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Neutralization of Infectivity of Diverse R5 Clinical Isolates of Human Immunodeficiency Virus Type 1 by gp120-Binding 2′F-RNA Aptamers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

A drug-loaded aptamer-gold nanoparticle bioconjugate for combined CT imaging and therapy of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Prostate cancer cell death produced by the co-delivery of Bcl-xL shRNA and doxorubicin using an aptamer-conjugated polyplex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Molecular imaging of a cancer-targeting theragnostics probe using a nucleolin aptamer- and microRNA-221 molecular beacon-conjugated nanoparticle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Self-assemble gene delivery system for molecular targeting using nucleic acid aptamer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Molecular biology of anaplastic lymphoma kinase-positive anaplastic large-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Targeted chemoimmunotherapy using drug-loaded aptamer-dendrimer bioconjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Directed evolution of gold nanoparticle delivery to cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Targeting the brain with PEG-PLGA nanoparticles modified with phage-displayed peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Inhibition of cell proliferation by an anti-EGFR aptamer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Aptamer-incorporated hydrogels for visual detection, controlled drug release, and targeted cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Crystal structure of an RNA aptamer bound to thrombin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Molecules in focus: tenascin-C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Aptamer directly evolved from live cells recognizes membrane bound immunoglobin heavy mu chain in Burkitt's lymphoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Cell specific aptamer-photosensitizer conjugates as a molecular tool in photodynamic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

A multivalent DNA aptamer specific for the B-cell receptor on human lymphoma and leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Targeted delivery of chemotherapy agents using a liver cancer-specific aptamer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

In vivo selection of tumor-targeting RNA motifs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Advances in tenascin-C biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Dual-aptamer-based delivery vehicle of doxorubicin to both PSMA (+) and PSMA (-) prostate cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Protection of HIV neutralizing aptamers against rectal and vaginal nucleases: implications for RNA-based therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

RNA aptamers selected against the receptor activator of NF-kappaB acquire general affinity to proteins of the tumor necrosis factor receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

UCLA1, a synthetic derivative of a gp120 RNA aptamer, inhibits entry of human immunodeficiency virus type 1 subtype C

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

An aptamer-siRNA chimera suppresses HIV-1 viral loads and protects from helper CD4(+) T cell decline in humanized mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Nucleic acid aptamers: clinical applications and promising new horizons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Prostate-targeted radiosensitization via aptamer-shRNA chimeras in human tumor xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Aptamers: an emerging class of therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Development of universal antidotes to control aptamer activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Efficient synthesis of nucleic acids heavily modified with non-canonical ribose 2'-groups using a mutantT7 RNA polymerase (RNAP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

RNA aptamers directed to human immunodeficiency virus type 1 Gag polyprotein bind to the matrix and nucleocapsid domains and inhibit virus production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Controlled and targeted tumor chemotherapy by ultrasound-activated nanoemulsions/microbubbles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

RNA aptamers as reversible antagonists of coagulation factor IXa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Gold nanoparticle-assisted delivery of small, highly structured RNA into the nuclei of human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Aptamers evolved from live cells as effective molecular probes for cancer study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Aptamers evolved from cultured cancer cells reveal molecular differences of cancer cells in patient samples.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Cell-specific aptamer probes for membrane protein elucidation in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Identification of liver cancer-specific aptamers using whole live cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Aptamer-based tumor-targeted drug delivery for photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

RNA aptamer against a cancer stem cell marker epithelial cell adhesion molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Paclitaxel and its formulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Aptamer-Functionalized In Situ Injectable Hydrogel for Controlled Protein Release

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Reflections on a novel therapeutic candidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

The nucleolin targeting aptamer AS1411 destabilizes Bcl-2 messenger RNA in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Targeted delivery of daunorubicin to T-cell acute lymphoblastic leukemia by aptamer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

PEGylated anti-MUC1 aptamer-doxorubicin complex for targeted drug delivery to MCF7 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Designer tridentate mucin 1 aptamer for targeted drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Selection of aptamers for molecular recognition and characterization of cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Intracellular delivery of RNA-based therapeutics using aptamers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Delivery of chemo-sensitizing siRNAs to HER2+-breast cancer cells using RNA aptamers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Regulation of peripheral B cell maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Viral capsid DNA aptamer conjugates as multivalent cell-targeting vehicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Signal transduction by receptors with tyrosine kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Surface-immobilized aptamers for cancer cell isolation and microscopic cytology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Nanotextured substrates with immobilized aptamers for cancer cell isolation and cytology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Regulation of cellular iron metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Aptamer-conjugated nanobubbles for targeted ultrasound molecular imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Aptamer-conjugated and drug-loaded acoustic droplets for ultrasound theranosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Inhibition of HIV transmission in human cervicovaginal explants and humanized mice using CD4 aptamer-siRNA chimeras

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Developing aptamers into therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

DNA aptamer-micelle as an efficient detection/delivery vehicle toward cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Cell-specific internalization study of an aptamer from whole cell selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Near-infrared light-triggered, targeted drug delivery to cancer cells by aptamer gated nanovehicles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Generating aptamers by cell-SELEX for applications in molecular medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

One-step engineering of silver nanoclusters-aptamer assemblies as luminescent labels to target tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Novel aptamer-nanoparticle bioconjugates enhances delivery of anticancer drug to MUC1-positive cancer cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Image-guided prostate cancer therapy using aptamer-functionalized thermally cross-linked superparamagnetic iron oxide nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Using an RNA aptamer probe for flow cytometry detection of CD30-expressing lymphoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Initial investigation of acoustic droplet vaporization for occlusion in canine kidney.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

A novel aptamer developed for breast cancer cell internalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

A nanocomplex that is both tumor cell-selective and cancer gene-specific for anaplastic large cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Prodrug strategy for PSMA-targeted delivery of TGX-221 to prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Aptamer-targeted RNAi for HIV-1 therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Novel dual inhibitory function aptamer-siRNA delivery system for HIV-1 therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Selection, characterization and application of new RNA HIV gp 120 aptamers for facile delivery of Dicer substrate siRNAs into HIV infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Dual functional RNA nanoparticles containing phi29 motor pRNA and anti-gp120 aptamer for cell-type specific delivery and HIV-1 inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Self-assembled aptamer-based drug carriers for bispecific cytotoxicity to cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

Metastasis-focused cell-based SELEX generates aptamers inhibiting cell migration and invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-013-0227-0

10.1007/S00005-013-0227-0

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

28 August 2017

1001268530

0 references

1 reference